Scientific publications

Frontiers in Immunology, 2026

APASL-ACLF without previous decompensation is immunologically distinct from EASL-CLIF-ACLF with previous decompensation

Langer M., Weiss M., Bauschen A. et al.

The Ocular Surface, 2026

Efficacy and safety of 20% and 100% autologous serum eye drops in patients with severe dry eye disease: a prospective, blinded, randomized, crossover study

Roels D., van Gremberghe I., Huys L. et al.

Communications Medicine, 2026

Proteomic profiling of liver and plasma uncovers biomarkers and mechanisms in patients with primary biliary cholangitis

Kellemann J., Jensen A., Nielsen A. et al.

Heart, 2026

Plasma heart-type fatty acid-binding protein, omega-3 fatty acids and adverse cardiac events in the general population

Lyu J., Qian Y., Xu Z. et al.

Kidney Medicine, 2026

Risk Prediction of Incident Chronic Kidney Disease Using Plasma Proteomics in Individuals Without Diabetes

Abbasi M., Missikpode C., Verma A. et al.

Microchemical Journal, 2026

Olink proteomics identifies a diagnostic signature for unstable angina and predictive biomarkers for in-stent restenosis

Wang F., Liu X., Hao X. et al.

Nature Communications, 2026

SARS-CoV-2-specific monoclonal antibody AER002 in Long COVID: an exploratory randomized phase 2a mechanistic trial

Peluso M., Ryder D., Dalhuisen T. et al.

International Journal of General Medicine, 2026

Cytokine Concentrations in Seminal Plasma and Blood in HIV Infection: Differential Modulation by Antiretroviral Therapy and Association with HIV RNA Levels and CD4+T Cell Count

Gao D., Mijiti Z., Zhu N. et al.

Molecular Medicine, 2026

The protein kinase IKK epsilon shapes the melanoma tumor microenvironment by modulating angiogenesis and the T-cell immunity

Haß M., Mungo E., Benning D. et al.

The Lancet Rheumatology, 2026

Cellular and proteomic changes following administration of peresolimab in patients with rheumatoid arthritis: a post-hoc analysis of a randomised phase 2a trial

Benschop R., Tuttle J., Emery P. et al.

Liver International, 2026

Distinct Plasma Proteomic Signatures Distinguish MASLD From Non‐Steatotic Individuals but Not From MetALD

Jakhar N., Seibel T., Mironova M. et al.

Molecular & Cellular Proteomics, 2026

Proteomic Profiling of Post-COVID -19 Sequelae

Golriz Khatami S., Baumkötter R., Köck T. et al.

Endocrine, 2026

Exploration of cytokines relating to masked obesity in Japanese women

Ishibashi C., Nakanishi K., Nishida M. et al.

Journal of Gastric Cancer, 2026

Biological Redefinition of Oligometastatic Gastric Cancer Refines Surgical Risk Stratification

Wu Y., Wang Z., Fu M. et al.

Nature Communications, 2026

An epigenetic aging-informed dietary pattern is associated with a spectrum of aging-related health outcomes

Lai S., Yu J., Zhang L. et al.

Science Advances, 2026

Multimodal profiling of atherosclerosis: Protocol and pilot data for the AtherOMICS biobank

Živković L., Batool R., Louma J. et al.

Emerging Microbes & Infections, 2026

Sequential combination of anti-PD-1 antibody and PEG-IFNα in chronic hepatitis B patients: correlates of HBsAg loss with enhanced T-cell responses

Wang H., Zhang C., Li X. et al.

BMC Gastroenterology, 2026

Biological ageing-related plasma proteomics improves chronic liver disease prediction: a prospective UK Biobank study

Ding J., Zhou Y., Liu Y. et al.

Journal of Arrhythmia, 2026

Genetically Predicted Gut Microbial Taxa and Inflammatory Proteins Associated With Atrial Fibrillation: A Bidirectional Mendelian Randomization and Colocalization Study

Yi C., Zheng W., Zhao J. et al.

PLOS One, 2026

Proteomic machine-learning signatures associated with carotid plaque: A population-based hypothesis-generating study

Szpakowicz A., Lesiński W., Tuchliński J. et al.